Study: Immune cells help pancreatic cancer to spread in the body

In a new scientific paper published in the journal “Nature Kante”, a certain group of immune cells played a major role in creating an environment that can spread cancer cells in other body parts. These immune cells change the behavior of other immune cells in the body, making them less effective in attacking cancer cells. As a result, the environment around the cancer cells becomes less suitable for the natural defense of the body, making it easier for cancer cells to survive and grow without attacking. The article explains new visions, regarding a practical role known as “the large number of efficacy”, in the transfer of pancreatic cancer to the liver. The large number of effectiveness is a process that swallows cells, removes cells, cells and other unwanted materials, or damaged from the body. This process plays a crucial role in maintaining tissue balance, preventing inflammation and preventing the content of the potential harmful cells of dead cells. During this process, specialized cells that are called and swallowed by cellular cells by connecting specific receptors on the surface of the looted cells on the surface of dead cells. About 50% of patients with the pancreatic cancer suffer from the purpose of liver cancer; Unfortunately, there is currently no effective treatment for these patients. This study represents an important step forward in understanding the mechanisms behind the transfer of cancer from the liver pancreas, and also brings hope to develop effective treatments for patients who experience this aggressive disease. A promising therapeutic approach, and this study, conducted by researchers at the University of Liverpool, found that the metal of the pancreatic tumors shows high levels of these immune suppressing balsamic cells. They also discovered that the course of the “regular grains” process during the early stage of the malignant pancreas crop, which prevented this immune suppressing activity in the pharynx, recycled the activation of T -cells and reduced the metastatic crop burden. The research confirms that the target of these specified type of immune cells, or interferes with the immune suppressing functions; It can serve as a ‘promising therapeutic approach’ for patients suffering from metric cancer. According to the researchers; If we can find a way to turn these set immune cells from work, or prevent them from making the environment around the cancer cells less appropriate, it can be a useful treatment for people with a metastatic pancreatic cancer. By doing so, we can facilitate the body’s immune system to identify and attack cancer cells, which can improve the results of patients.